North Texas Renal Management, LLC
About
Issuer
- Entity type
- Limited Liability Company
- Jurisdiction
- Texas
- Sector
- Healthtech
- Headquarters
- Dallas, TX
- Street
- 1505 Lbj Freeway
- Zip
- 75234
Offering
- Total offering
- $9.8M
- Amount sold
- $564k
- First sale
- Dec 31, 2025
- Min investment
- $0
- Securities
- Equity
- Federal exemption
- Rule 506(b)
- Investors so far
- 2
How this filing compares
Ranked #17 of 63 Healthtech filings in April 2026 by offering amount.
Median Healthtech filing in April 2026: $3.4M. This offering is 2.9× the median.
Other Texas filings this week: 1700 Northgate Partners LLC, 90Ten EDGE Central II Syndicate, LLC, Acacia Partners Investments IV - AI, LLC, Acacia Partners Investments IV - QP, LLC, Americana - LGP Series 2026, LP
Leadership
Geoffrey S. Walker — Executive Officer (also: Director)
Also named on: North Texas Renal Management V, LLC, North Texas Renal Management VI, LLC, North Texas Renal Management VII, LLC
Joris M. Schuller — Executive Officer (also: Director)
Richard n/a Fuquay — Director
Anupkumar n/a Shetty — Executive Officer (also: Director)
Venkata n/a Yalamanchili — Director
Filing details
North Texas Renal Management, LLC filed a Form D with the SEC on April 14, 2026.